Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01337063 · ClinicalTrials.gov registry record · NA
Multi-Center Medication Reconciliation Quality Improvement Study
A NA study of Adverse Drug Events and Medication Administered in Error, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 1,836
- Enrollment target
- 6
- Study locations
NCT01337063: Completed NA study of Adverse Drug Events and Medication Administered in Error, sponsored by Brigham and Women's Hospital.
NCT01337063 is a NA study of Adverse Drug Events and Medication Administered in Error that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 1,836 participants, above the 483-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (280% higher). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01337063, a NA study of Adverse Drug Events and Medication Administered in Error, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,836 participants
- Enrollment target
- 6
- Study locations
Study Summary
Patients often have problems after they leave the hospital, in part because errors are made in the medications they are prescribed. The goal of this project is to develop a more accurate and safe medication prescription process when patients enter and leave the hospital and implement this process at six U.S. hospitals. The investigators will measure the success of the project and develop lessons learned so this process can be applied to other hospitals.
Primary Outcome
The primary outcome will be determined by a study pharmacist who will take a "gold standard" medication history on 5 patients per week, then compare that history to the medical team's medication history, to admission orders, and to discharge orders. Any unintentional medication discrepancies in orders will be recorded. A physician adjudicator will then make a final determination regarding whether an error occurred, the type of error, the potential for patient harm, and the potential severity.
Conditions Studied
Interventions
- OTHER Mentored medication reconciliation quality improvement
Study Locations (6)
California
- University of California, San Francisco - San Francisco
Georgia
- Emory Johns Creek Hospital - Johns Creek
Illinois
- University of Chicago Hospitals and Clinics - Chicago
Massachusetts
- Baystate Health - Springfield
North Carolina
- Presbyterian Hospital - Charlotte
South Dakota
- Sioux Falls VA Medical Center - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,836 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-09 |
| Phase | NA |
What the finished NCT01337063 record still lists
NCT01337063 is an interventional study that assigns participants to a tested intervention. Its 1,836 participants enrollment target places it among the larger protocols in the corpus, above the 483-participant average among 6 other Adverse Drug Events trials with a reported enrollment target (280% higher).
The record links to 2 conditions, with Adverse Drug Events appearing as the primary indexed condition, and to 1 intervention - of which Mentored medication reconciliation quality improvement is the first listed.
NCT01337063 lists 6 locations in 6 states (California, Georgia, Illinois).
Frequently Asked Questions
What is clinical trial NCT01337063 about?
NCT01337063 is a clinical study titled "Multi-Center Medication Reconciliation Quality Improvement Study". Patients often have problems after they leave the hospital, in part because errors are made in the medications they are prescribed. The goal of this project is to develop a more accurate and safe medication prescription process when patients enter and leave the hospital and implement this process at...
What is the current status of trial NCT01337063?
This trial is currently completed. It is a NA study. The enrollment target is 1,836 participants. The study started on 2011-03. Estimated completion is 2014-09.
What conditions does trial NCT01337063 study?
This clinical trial studies the following conditions: Adverse Drug Events, Medication Administered in Error.
What interventions are being tested in trial NCT01337063?
The interventions under investigation include: Mentored medication reconciliation quality improvement (OTHER).
Who is sponsoring clinical trial NCT01337063?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01337063 being conducted?
This trial has 6 study locations across California, Georgia, Illinois, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adverse Drug Events
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Geriatric Emergency Department Pharmacologic Harm Prevention Project
RECRUITING · NA
-
Patient Profiling and Provider Feedback to Reduce Adverse Drug Events
COMPLETED · NA
-
The Secure Messaging for Medication Reconciliation Tool (SMMRT) Trial
COMPLETED · NA
-
Enhancing the Detection and Management of Adverse Drug Events in Nursing Homes
COMPLETED · NA
-
Improving Safety by Basic Computerizing Outpatient Prescribing
COMPLETED · Phase 2
-
Response to Medication Registry
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia